Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India: a systematic review and meta-analysis AS Bhagavathula, K Vidyasagar, M Chhabra, M Rashid, R Sharma, ... Frontiers in pharmacology 12, 685518, 2021 | 36 | 2021 |
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized phase II/III trials AS Bhagavathula, K Vidyasagar, W Tesfaye Pharmaceuticals 14 (10), 991, 2021 | 35 | 2021 |
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis … S Chenchula, K Vidyasagar, S Pathan, S Sharma, MR Chavan, ... Scientific reports 13 (1), 6415, 2023 | 27 | 2023 |
The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an … C Santenna, K Vidyasagar, KC Amarneni, SN Ghanta, B Sadasivam, ... Therapeutic Advances in Drug Safety 12, 20420986211042517, 2021 | 24 | 2021 |
Potentially inappropriate medication use in older hospitalized patients with type 2 diabetes: a Cross-Sectional Study R Sharma, M Chhabra, K Vidyasagar, M Rashid, D Fialova, ... Pharmacy 8 (4), 219, 2020 | 22 | 2020 |
Hepatocellular carcinoma recurrence and mortality rate post liver transplantation: meta-analysis and systematic review of real-world evidence KI Bzeizi, M Abdullah, K Vidyasagar, SA Alqahthani, D Broering Cancers 14 (20), 5114, 2022 | 15 | 2022 |
Knowledge and attitude towards HIV/AIDS in India: A systematic review and meta-analysis of 47 studies from 2010-2020 AS Bhagavathula, CCT Clark, R Sharma, M Chhabra, K Vidyasagar, ... Health promotion perspectives 11 (2), 148, 2021 | 15 | 2021 |
Sweetened beverage consumption and risk of cardiovascular mortality: a systematic review and meta-analysis AS Bhagavathula, J Rahmani, K Vidyasagar, W Tesfaye, J Khubchandani Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (4), 102462, 2022 | 13 | 2022 |
Organic food consumption and risk of obesity: a systematic review and meta-analysis AS Bhagavathula, K Vidyasagar, J Khubchandani Healthcare 10 (2), 231, 2022 | 11 | 2022 |
Polypharmacy and hyperpolypharmacy in older individuals with Parkinson’s disease: a systematic review and meta-analysis AS Bhagavathula, W Tesfaye, K Vidyasagar, D Fialova Gerontology 68 (10), 1081-1090, 2022 | 11 | 2022 |
Tezepelumab for patients with severe uncontrolled asthma: a systematic review and meta-analysis Z Zoumot, N Al Busaidi, W Tashkandi, AA Aljohaney, S Isse, K Vidyasagar, ... Journal of Asthma and Allergy, 1665-1679, 2022 | 11 | 2022 |
Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis. Front Pharmacol … AS Bhagavathula, K Vidyasagar, M Chhabra, M Rashid, R Sharma, ... | 9 | 2021 |
Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies M Chhabra, K Vidyasagar, SK Gudi, J Sharma, R Sharma, M Rashid Plos one 17 (7), e0269531, 2022 | 7 | 2022 |
Phosphodiesterase type 5 inhibitors use and risk of colorectal cancer: a systematic review and meta-analysis AS Bhagavathula, W Tesfaye, K Vidyasagar International Journal of Colorectal Disease, 1-8, 2021 | 6 | 2021 |
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis C Carcel, F Haghdoost, J Shen, P Nanda, Y Bai, E Atkins, ... Cephalalgia 43 (6), 03331024231183166, 2023 | 5 | 2023 |
Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants AS Bhagavathula, B Woolf, J Rahmani, K Vidyasagar, W Tesfaye European Journal of Clinical Pharmacology 78 (4), 547-555, 2022 | 4 | 2022 |
Efficacy and safety of commonly used insulin analogues in the treatment of diabetic ketoacidosis: a bayesian indirect treatment comparison K Vidyasagar, B Chandrasekar, M Chhabra, A Bhansali, D Bansal Clinical Therapeutics 42 (8), e115-e139, 2020 | 4 | 2020 |
Pattern, severity, and outcome of adverse drug reactions in a tertiary care hospital: an evidence from a cross-sectional study M Chhabra, MS Jangra, M Rashid, P Sharma, K Vidyasagar Journal of Basic and Clinical Physiology and Pharmacology 33 (6), 815-822, 2022 | 3 | 2022 |
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension R Kanukula, R Dhurjati, K Vidyasagar, N Rehana, A Talari, A Salam, ... BMJ Evidence-Based Medicine 27 (2), 79-86, 2022 | 3 | 2022 |
Quality of the Indian clinical practice guidelines for the management of cardiovascular conditions R Dhurjati, V Sagar, R Kanukula, N Rehana, PP Mohanan, MD Huffman, ... JRSM open 13 (12), 20542704221127178, 2022 | 1 | 2022 |